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Abstract 
Introduction: The HIV epidemic has had a significant impact on the existing 
inpatient and outpatient health systems. The cost of inpatient care for HIV positive 
people has been shown to be greater than for HIV negative people and HIV infection 
has been associated with a higher inpatient mortality. These dynamics, in the face of 
an established antiretroviral program, have not been studied at district hospital level 
previously. 
Aim: The aim of this study was to describe the clinical patterns and cost implications 
in medical admissions at Helderberg Hospital, with particular reference to HIV 
infection and treatment. It includes a comparative analysis of HIV positive and HIV 
negative admissions. 
Methodology: This was a descriptive, quantitative study in the form of a cross-
sectional survey. All medical admissions over defined 24 hour periods were recorded 
and data extracted from the medical records retrospectively.  
Results: 165 records were analysed. HIV prevalence was 19% and overall mortality 
7%. 23(72%) of the 32 HIV positive patients had not yet accessed HIV services. The 
median CD4 count was 87cells/microl. The comparative analysis showed the HIV 
positive admissions to have a longer length of stay (5.9 days versus 3.6 days, p<0.01), 
higher laboratory costs (R717.28 versus R327.23, p<0.01) and higher pharmacy costs 
(R40.69 versus R11.72, p<0.01) than the HIV negative admissions. Outcomes for the 
HIV positive and negative patients were similar (p=0.64).  
Conclusion: Inpatient cost of care for HIV positive patients in this district hospital is 
more expensive than for HIV negative patients. Mortality rates in both groups are 
comparable. Antiretroviral therapy may be contributing to a decreased inpatient HIV 
prevalence and mortality rate. HIV positive patients are not accessing treatment in 
time to avoid morbidity requiring costly hospital admission. Further efforts are needed 
to expand outpatient HIV services, to explore the reasons why people with HIV are 
not accessing treatment timeously and to encourage rigorous treatment of HIV 
infected inpatients to ensure optimal outcomes.  
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Introduction 
 
South Africa has the largest number of HIV infections in the world. The increasing 
prevalence of HIV infection has been well documented in the antenatal clinic 
screening program which has seen a rise from 22% to 30% between 1999 and 2005.
1
 
Although the epidemic appears to be stabilizing, it continues to exert significant 
pressure on the health care systems. This study explores the extent of HIV infection 
and antiretroviral therapy (ART) use in the medical admissions at the state run 
Helderberg Hospital situated in the Western Cape. It also compares specific costs 
incurred to the hospital by HIV positive patients with that of HIV negative patients 
and the clinical outcomes of these two groups. 
 
The study was undertaken to gain a better understanding of the clinical patterns and 
cost implications of HIV at Helderberg Hospital. Although similar studies have been 
conducted elsewhere,
2,3,4
 they have been done prior to or in the early stages of the 
ART program and not at a district hospital level with an established national ART 
service. The findings will provide staff and policy makers with better insight into the 
profile of the medical admissions and the impact that HIV may have on the hospital 
resources. It will also emphasize the work that is done for HIV negative patients and 
the possible impact that the burden of HIV has on this group of patients. 
Understanding these dynamics empirically will have significance for future planning 
and budget decisions.  
 
The South African Government implemented a national antiretroviral program in 
2004 and, according to a progress report from the Department of Health, by 2007 55% 
of those HIV infected individuals requiring ART had access to treatment.
5 
Recent 
figures show that there are 59823 people in the Western Cape who are currently in 
care, receiving ART. The program is expanding rapidly: in 2004 less than 400 
patients were enrolled in the program every month. Five years later this number has 
increased to more than 1400 people.
6
  
 
In the six months prior to this study an average of 62 people were initiated on ART 
every month in the Helderberg Hospital drainage area. This amounts to an estimated 
73% of those in need of treatment for the area.
7,8
 Although this represents a 
considerable effort, there are still more than 25% of HIV positive patients who are not 
accessing ART thus risking severe immunocompromise and opportunistic infections 
requiring hospital admission. A predominance of such patients in the hospital 
admissions would justify strengthening the outpatient facilities. 
 
 
Literature search 
 
The literature search concentrates on African studies which focus on medical 
admissions, particularly HIV infected patients and compare clinical outcomes and 
costs between HIV positive and HIV negative admissions. 
 
HIV prevalence in hospital admissions 
HIV positive medical admissions have been increasing in hospitals all over East and 
Southern Africa since the late 1980’s.9,10 This has been accompanied by changing 
trends of illness with an increase in infectious diseases and a decrease in 
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cardiovascular diseases.
10 
In numerous studies HIV prevalence amongst inpatients 
was found to be around 50%
11,12
 including a study in Soweto in 2005 which showed 
68% of medical patients to be HIV positive.
2
  In the Western Cape (the province with 
one of  the lowest seroprevalence rates in South Africa
5
), prevalence was 33 – 43% in 
2003, in a secondary hospital with an HIV referral unit.
13 
In 2008, the average 
prevalence of HIV positive medical admissions in the City of Cape Town metropole 
was found to be 34%. (Point prevalence study of medical admissions, Cape 
metropole. Vanessa Burch, unpublished data.)
 
 
Length of stay 
It has been shown that up to 77% of the total costs of hospital admissions are related 
to the length of stay (LOS).
2
 If the impact of HIV is determined by cost then the 
length of stay of patients with HIV is a good guide to assess the impact it has on a 
health care system. The LOS for HIV positive patients compared to HIV negative 
patients has been determined in numerous studies and findings have differed in 
different parts of Africa.
2,11,12,14
 This is likely to be influenced by the level of 
available care, for example those health care systems that have access to ART and 
special investigations might invest more time in treating patients with advanced 
AIDS, whereas in areas of limited resources, these patients may die early in their 
admission or be discharged home for terminal care.
3
  
 
Costs 
Previous studies have reflected on the costs of inpatient care in HIV positive versus 
negative patients. In Kenya, in 1997, it was found that there was no significant 
difference in the costs per admission between the two groups.
3
 Eight years later in 
Soweto the difference in cost was marked, with HIV positive patients costing the 
health care system considerably more than the HIV negative patients.
2
 The difference 
between these two studies may be related to the use of ART which was only 
established after the Kenyan study. ART has been shown to be a cost effective 
intervention,
15
 however it has added a new dimension to the inpatient costs of 
patients. In Soweto, those HIV positive patients who were receiving ART incurred 
greater cost to the hospital and were admitted for significantly longer periods than 
those who were HIV positive and not on antiretroviral treatment.
2
 Whether this is due 
to increased survival, drug toxicity, or immune reconstitution is unclear.
2
 This raises 
important considerations for future budget planning relating to HIV care.  
 
Mortality 
HIV infection has been associated with a high mortality. Prior to antiretroviral 
treatment, mortality was shown to be nearly 70% at two years for stage 4 disease
16 
and HIV positive patients were shown to have an inpatient mortality rate of 22 – 
35%.
9,11
 Comparative inpatient mortality rates between HIV positive and negative 
admissions in Africa have shown a higher mortality in the HIV positive patients.
9,11,12 
In New York, following the introduction of ART, the inpatient mortality rate 
decreased by more than half over a six year period.
17 
There has been concern that 
there is an increased mortality in the HIV negative patients, possibly due to the 
increased burden of HIV on the health care system.
9
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Aim and objectives 
 
The aim of the study was to describe the clinical patterns and cost implications in 
medical admissions at Helderberg Hospital, Western Cape, South Africa, with 
particular reference to HIV infection and treatment. 
 
Objectives 
 To collect data from patients’ records admitted to the medical wards over defined 
periods and describe the profile of and HIV prevalence  in these patients 
 To describe the clinical patterns of disease, including mortality, of HIV positive 
and HIV negative admissions 
 To compare the cost implications of HIV positive and HIV negative admissions 
including the costs of resources such as laboratory tests, drugs and length of stay 
in the hospital 
 
Definition of terms: 
HIV positive: patients infected with the human immunodeficiency virus as determined 
by blood testing or by clinical criteria as detailed in the WHO clinical guidelines.
18
 
HIV negative: patients confirmed to not be infected with HIV through blood testing 
and those that are untested, but do not meet the clinical criteria. 
Medical admissions: those patients admitted via casualty to the department of Internal 
Medicine. 
  
 
Methodology 
 
This study was undertaken at Helderberg Hospital. This is a district hospital which 
drains the Helderberg Basin and, informally, the Grabouw region. Although it is 
classified as a district hospital, it provides both primary and secondary care. The 
people who attend this hospital are generally from lower socioeconomic groups, many 
of whom live in poorly resourced areas, including informal settlements. Patients seen 
at the hospital are either referred from outlying state run Primary Health Care Clinics 
or private General Practitioners. Others are self referred and seen as emergencies. 
HIV management has been established on an outpatient level. There is a state run 
antiretroviral clinic at the hospital and at two of the clinics. HIV testing is offered at 
all other government clinics, as is ongoing monitoring and treatment prior to the need 
for ART. When the patient meets the criteria for ART, they are referred to the 
designated ART clinics. Should the need for admission arise, these patients are 
admitted at Helderberg Hospital. 
 
This was a descriptive, quantitative study in the form of a cross-sectional survey. All 
patients admitted under the medical department of the Helderberg Hospital during 
specified 24 hour periods were included in the study. Three such periods per week, for 
seven weeks in November and December 2008, were used. This sampling technique 
avoided any bias in patient selection. The patient details were recorded at the time of 
admission and data was collected retrospectively from the patients’ files. A 
spreadsheet (Annexure 1) containing the relevant study variables (Table 1) was 
completed. These variables were chosen in order to fulfil the study objectives.  
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 Date of birth 
 Sex 
 Length of stay (days) 
 Laboratory costs (South African Rands) 
 Pharmacy costs (South African Rands) 
 High Care Unit admission (hours) 
 Diagnosis 
 HIV status (negative/ positive/ clinically assumed positive (WHO criteria18) 
without laboratory confirmation/ clinically assumed negative) 
 Clinical staging (WHO staging 1 - 4) 
 CD4 count within 6 months of admission if available (laboratory value 
cells/microl) 
 Antiretroviral therapy (on treatment/ not on treatment/ enrolled in the 
antiretroviral program, but not yet on treatment) 
 Outcome (death/ discharged/ transferred) 
Table 1. Variables on data collection spreadsheet 
 
 
One hundred and seventy one patient records were reviewed, of which 165 were 
suitable for analysis. Pharmacy costs were determined by calculating the cost per dose 
of each drug given. Drug lists were obtained from each patient’s drug chart and the 
hospital pharmacist provided the costs of the medications according to the Comeds 
contract (stipulated by the Department of Health). The laboratory costs were obtained 
from the National Health Laboratory Service. This included all tests which were 
requested by doctors during the patients’ admission. The length of stay, diagnosis and 
outcome were established through the clinical notes. 19 common diagnoses, 
determined from previous experience in the medical wards, were listed and assigned 
to the patients during data collection. The information in the patients’ files, recorded 
by the attending doctors, was used to determine the diagnoses. Patients with co-
morbidities were assigned more than one diagnosis. Those whose diagnosis did not fit 
the original list were recorded as ‘other’. The High Care Unit register was used to 
determine the length of any admissions here. Costs such as intravenous fluid and 
blood transfusions, syringes and needles and radiological investigations were not 
recorded due to limitations in securing this data. The length of stay was recorded as a 
comparative tool, rather than to contribute towards actual costs as with the laboratory 
and pharmaceutical costs. Thus the actual daily cost of admission was not determined, 
but the length of stay, determined in days from the admission date to the discharge, 
death or transfer date, was recorded. 
 
HIV testing was not done for study purposes, but doctors working in the medical 
wards followed existing hospital policy to encourage HIV testing (through voluntary 
counselling and testing) where appropriate in all medical patients. The recorded HIV 
status was based on information in the clinical notes and laboratory records. CD4 
counts were accepted if they had been done within 6 months of admission and WHO 
staging and enrolment in the antiretroviral program was assessed through the clinical 
notes. 
 
Unfortunately not all patient files could be found at the time of data collection, 
therefore as much information as possible was collected through existing hospital 
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records, such as laboratory records and ward registers. In such patients the missing 
information was the diagnosis, pharmacy costs and clinical information regarding 
HIV status.  
 
The data analysis was done using Statistica. The initial analysis examined all 165 
patients. A further comparative analysis was done by dividing the group into HIV 
positive and HIV negative patients using cross tabulations (with Chi-square test) for 
nominal data and the non-parametric Mann Whitney test for ordinal data.  
 
Permission to conduct research was requested from the hospital administration and 
ethical approval was obtained from the Committee for Human Research, University of 
Stellenbosch, South Africa. Patient confidentiality was maintained at all times as the 
author collected all the data and was the only person to access these files. 
Confidentiality was further protected through assigning study numbers to each 
patient, therefore names were not included in the data collection sheet.  
 
Results 
 
Records from 171 patients were reviewed. 6 records did not fulfil inclusion criteria as 
the patients were either admitted under the incorrect department or incorrect date. 165 
records were suitable for analysis. Of these, 18 patients’ recorded data had more than 
one variable missing due to lost files or pharmacy charts. Calculations for specific 
variables were based on the total number of values collected for individual variables, 
not the total of 165 patients analysed, unless the data had been secured in all 165 
cases. For example, where only 140 pharmacy records where collected, the median 
pharmacy cost was based on n=140.  
 
The mean age was 44.9 years (range 13 to 88 years) with 52% (n=85) male and 48% 
(n=80) female. 19% were HIV positive (n=32, including 2 who were untested but 
clinically fulfilled WHO criteria of AIDS). If those that were admitted for purely 
psychiatric reasons are excluded, this comes to an HIV prevalence of 22%. The mean 
length of stay was 4.08 days with a median pharmacy cost (fig.1) of R17.26 and 
laboratory cost (fig.2) of R278.27 per admission. Overall mortality was 7% (n=12) 
while 10% were transferred to a tertiary institution and 82% discharged home.  
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 Figure 1. Distribution of pharmacy costs  
 
 
 
 
 Figure 2. Distribution of laboratory costs  
 
 
Six (19%) of the 32 HIV positive patients were on ART, while a further 3 (9%) had 
already enrolled in HIV services at a designated ART clinic. 23 (72%) had not 
accessed treatment yet. The majority (21) of the HIV positive patients had recent CD4 
counts of less than 200/microl (fig.3) and all were assessed as WHO stage 3 or 4. 
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 Figure 3. Distribution of CD4 counts amongst HIV positive admissions 
 
 
 
Diagnoses: These are illustrated in fig.4 where 36% had an infective illness 
(tuberculosis, pneumonia, meningitis, urinary tract infection or gastroenteritis), 28% 
cardiovascular, 15% had a psychiatric diagnosis and 14% had diabetic related 
problems. There were 5% each of drug overdose, renal failure, asthma/chronic 
obstructive airways disease and 4% epilepsy. 15% were classified as ‘other’. This 
group included haematology, neurology and non-specific complaints. 25% of patients 
had more than one diagnosis. 
 
Tuberculosis was diagnosed in 21% of the patients. The diagnosis of pulmonary 
tuberculosis (WHO stage 3 disease) was not enough to assume underlying HIV 
infection due to the high prevalence of tuberculosis in the Western Cape, irrespective 
of HIV status.
19
 If those patients with tuberculosis in the assumed negative group 
were to be assumed positive then the percentage of HIV patients would increase to 
23% (an addition of 6 patients). However, a further 2% were confirmed as HIV 
negative and also diagnosed with pulmonary tuberculosis.  
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Figure 4. Recorded diagnoses  
 
High Care Unit admissions:  12 patients were admitted to High Care during their 
admission. 11 of these patients were HIV negative. The mean admission was 46.6 
hours. 2 died and 2 where transferred for specialist care or further investigation. The 
average age was 45 years. 
 
A comparative analysis between the HIV positive group and HIV negative group 
was done. 
 
Demographics: This revealed an equal distribution of HIV in the males (81% 
negative; 19% positive) and females (80% negative; 20% positive). The mean age 
(fig.5) of the HIV positive group was 35.4 years and the HIV negative group 47.2 
years. (p<0.01) 
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Figure 5. Comparison of the mean age of HIV negative and HIV positive patients 
 
 
Outcome: 80% of the HIV negative patients were discharged, 8% died and 13% were 
transferred to a specialist unit, either Tygerberg Hospital (n=9) or Lentegeur 
Psychiatric Hospital (n=8). None of the HIV positive patients were transferred, 94% 
were discharged and 6% died. When the patients who were transferred are excluded 
from the analysis the outcomes of the positive and negative groups are comparable 
(fig.6) with 6% and 9% dead and 94% and 91% discharged respectively (p= 0.64). 
 
 
Figure 6. Comparative outcomes of the HIV negative and HIV positive patients 
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Length of stay: The mean LOS (fig.7) for HIV negative patients was 3.6 days 
compared to 5.9 days in the HIV positive group (p<0.01). 
 
 
Figure 7. Comparison of the mean length of stay between the HIV negative 
and HIV positive patients 
 
Costs: The mean laboratory cost per admission (fig.8) for HIV positive patients was 
R717.28 and R327.23 for the HIV negative group (p<0.01). The pharmacy cost 
analysis (fig.9) was skewed by an extreme outlier in the HIV negative group therefore 
the means are not a good reflection of the analysis. The median cost for HIV positive 
patients was R40.69 and R11.72 for HIV negative patients (p<0.01). 
Figure 8. Comparison of the mean laboratory costs of the HIV negative and 
HIV positive patients 
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Figure 9. Comparison of the distribution of pharmacy costs of the HIV negative and 
HIV positive patients 
 
 
 
Discussion 
 
The analysis provides some important insights into the medical patients at Helderberg 
Hospital. The HIV prevalence of 19 - 22% is lower than expected. It is possible that 
there were some HIV positive patients in the group of assumed negative patients due 
to the fact that routine testing was not applied and that there were no clinical features 
of underlying HIV infection.  
 
Previous audits of the medical admissions at Helderberg Hospital have consistently 
shown an HIV prevalence of 25 - 30% (Katrin Stüve, unpublished data). However, the 
overnight ward admissions, including most of the psychiatric patients and high 
turnover admissions, were not included in these figures. It is therefore possible that 
the inclusion of these patients in this study may skew the overall prevalence.  
 
Many patients who attend Helderberg Hospital, particularly those that live in informal 
settlements where HIV prevalence is high,
20
 return to the Eastern Cape in December. 
It is possible that this may contribute to the unexpectedly low inpatient HIV 
prevalence in this study. The records of ART initiation rate in the Western Cape show 
a consistent dip each year in December,
6
 partly due to this December migration.  
 
In terms of cost, the HIV positive patients contribute a significantly greater burden to 
the hospital than the HIV negative patients. HIV positive patients cost more in both 
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pharmacy and laboratory costs and spend more days in hospital than their HIV 
negative counterparts. These findings are in line with other South African studies
2,4 
 
done prior to or in the early stages of the national ART program. 
 
Despite the extensive ART program operating in the area for the last 5 years, the 
majority of HIV positive patients had not yet accessed treatment and many were 
diagnosed during this hospital stay. The incidence of opportunistic diseases increases 
when the CD4 count is less than 200/microl.
21
 ART is also most effective and 
associated with less morbidity and mortality when started before this level of 
immunocompromise has been reached.
22,23
 Considering that the majority of the HIV 
positive patients had CD4 counts of less than 200/microl and had not yet commenced 
with ART, it is reasonable to assume that this costly admission could have been 
averted if ART was commenced  before the CD4 count dropped below 200. Indeed it 
has been shown that it is cheaper to treat HIV patients in the outpatient setting
24
 than 
as an inpatient. It is therefore clear that with an improved outpatient facility providing 
diagnosis, monitoring and treatment of HIV, the immense cost of inpatient care can be 
decreased. The morbidity associated with advanced immunocompromise could be 
avoided and limited hospital resources could be diverted to non-HIV related illnesses.  
 
A small audit done in the HIV services of the Helderberg area found that stigma still 
remains an important reason why people do not access the pre-ART HIV wellness 
services. There is a perception that the clinic services are of a poor standard with 
overcrowding and long waiting times. There also appears to be a lack of 
understanding of the need for regular follow up while HIV positive people are 
relatively well (Katrin Stüve unpublished data). This may explain why the numbers of 
patients with advanced HIV infection who have not yet accessed treatment are still 
high. 
 
The lower than expected prevalence of HIV in the hospital admissions may be a 
reflection of an ART program that is operating efficiently, diagnosing and treating 
patients before they reach such an advanced stage. Therefore, the ART program may 
be keeping patients out of hospital thus reducing the burden of HIV in the inpatient 
setting.  
 
Although there is an adequate ART program in place to decrease the admissions, there 
is still a need to expand these services at an outpatient level to ensure that more 
people are tested and enrolled into HIV care. This will need to include community 
educational programs to ensure that HIV positive people understand the need to 
adhere to pre-ART care and there needs to be further efforts to decrease the stigma 
associated with HIV infection. 
 
This study has revealed that outcome is not related to HIV status. This implies that 
although the cost of treating HIV positive patients is great, their outcome is on a par 
with the HIV negative patients. The question can be asked whether this is a reflection 
of decreased care towards the HIV negative patients due to the increasing burden of 
HIV, or an improving mortality rate in HIV positive patients due to ART. 
Importantly, the patients who are HIV positive are younger than the HIV negative 
patients and therefore are still potentially economically active and are likely to have 
young children requiring care. This emphasizes the need to support rigorous inpatient 
treatment for HIV positive patients while simultaneously expanding the ART program 
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in the province and nationally in a hope to eventually decrease these admissions and 
the associated mortality.  
 
The reality of only 19% of patients being HIV positive is that 81% of patients were 
HIV negative, either through testing or through clinical assumption. Experience at 
Helderberg Hospital is that the overwhelming feeling amongst doctors working in the 
medical department is that the clinical burden of HIV is extreme. Perhaps this is due 
to the fact that medical staff spend more time, per patient, on HIV positive patients 
than HIV negative patients due to their prolonged stay in hospital. However, this 
study emphasizes the amount of care given to HIV negative patients and dispels the 
myth that HIV is all that is seen in state sector medical wards. 
 
On completion of the research, the findings were presented to the doctors at 
Helderberg Hospital to increase awareness regarding hospital costs and HIV treatment 
within the hospital. This will hopefully translate into improved patient care and 
improve morale with regards to the outcome of HIV positive patients. The final 
document will be sent to the hospital administration to assist with budget decisions 
and planning. 
 
 
Limitations 
 
Patient sampling was designed to not discriminate between those patients who were 
HIV positive or negative and it was assumed that the sampling would be a true 
reflection of the admissions to the medical department on an ongoing basis. 
Admissions to the hospital are influenced by the casualty doctors. Doctors vary on 
their thresholds to admit sick patients. It is possible that some doctors may be more or 
less sympathetic to HIV positive patients. It is hoped that, no matter which doctor was 
on duty, their threshold for admitting would be constant and therefore there would be 
equal proportions of negative and positive patients being discharged from casualty 
who might have been admitted by a different doctor.  
 
The sample size was adequate to comment on the differences within this sample. 
However, a larger sample may have revealed different trends which may be a better 
reflection of the current situation at Helderberg Hospital. 
 
The fact that this study was carried out during November and December may have 
affected the total number of admissions and the HIV prevalence due to the 
abovementioned annual holidays of many of the patients during this period.  
 
The recorded diagnoses were dependant on the clinical notes. These notes varied in 
expertise and completeness. Therefore, the diagnoses should be considered a guide 
and may not reflect accurate numbers or medical information.  
 
Limited variables were used to compare cost. A more inclusive costing analysis may 
have differed from these findings.  
 
The medical department at Helderberg Hospital provides inpatient psychiatric care. It 
is not specified whether other studies on this subject have included psychiatric 
patients, therefore comparisons with their figures may be limited. However, they have 
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been included in this study as this is a true reflection of the current situation at this 
hospital. It is possible that their inclusion has skewed the figures, particularly the HIV 
prevalence, transfer rate and the LOS (the average LOS for a psychiatric patient 
awaiting transfer to a psychiatric hospital was 8.8 days). 
 
This study was a quantitative analysis. This limits the study’s ability to answer all the 
questions regarding the comparative impact of HIV infection at Helderberg Hospital. 
It is possible that a qualitative arm could have shed some light on the greater impact 
of HIV, particularly concerning the perceptions of the staff who provide care to the 
medical patients.  
 
 
Conclusion 
 
The prevalence of HIV infection in the medical admissions at Helderberg Hospital is 
19% which is lower than expected. Inpatient care for HIV positive patients is more 
expensive than for HIV negative patients and HIV positive patients spend more days 
in hospital than HIV negative patients. However, overall mortality rates for these two 
groups are similar. The ART program may be reducing inpatient HIV prevalence and 
mortality in the HIV positive patients. HIV positive patients are still not accessing 
treatment before they develop opportunistic infections despite the existing HIV 
services in the area. These services will need to expand in order to facilitate early 
diagnosis of HIV and appropriate initiation of ART to limit the costly admissions of 
HIV positive people. Further qualitative studies are required to address the reasons 
why HIV infected people are not accessing the available treatment in the community. 
Doctors should be encouraged to treat HIV infected patients rigorously to maintain 
good outcomes.  
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This data collection table was used in the form of an Excel spreadsheet (Microsoft 
Office 2003) where the type of variable was pre-programmed to include the different 
choices per variable. For example, for diagnosis, a number was assigned to each of 
the 19 predetermined diagnoses and the number which corresponded to the diagnosis 
was recorded for each patient.  
 
Annexure 1: Data collection spreadsheet 
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